TREMELIMUMAB\TREMELIMUMAB-ACTL for Hepatocellular carcinoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 589 adverse event reports in the FDA FAERS database where TREMELIMUMAB\TREMELIMUMAB-ACTL was used for Hepatocellular carcinoma.

Most Reported Side Effects for TREMELIMUMAB\TREMELIMUMAB-ACTL

Side Effect	Reports	%	Deaths	Hosp.
Diarrhoea	109	9.3%	26	63
Death	106	9.0%	106	4
Malignant neoplasm progression	101	8.6%	38	12
Cytokine release syndrome	86	7.3%	14	34
Immune-mediated enterocolitis	63	5.4%	18	40
Liver disorder	62	5.3%	8	19
Pyrexia	61	5.2%	11	28
Rash	60	5.1%	4	24
Colitis	47	4.0%	12	24
Immune-mediated hepatic disorder	45	3.8%	6	19
Interstitial lung disease	41	3.5%	20	23
Hepatic function abnormal	39	3.3%	6	18
Adrenal insufficiency	30	2.6%	5	11
Myocarditis	29	2.5%	14	17
Malaise	28	2.4%	6	11